FFA
DSGN icon

Farther Finance Advisors’s Design Therapeutics DSGN Stock Holding History

Farther Finance Advisors’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$478 Buy
38
+18
+90% +$249 ﹤0.01% 5754
2026
Q2 		$289 Sell
20
-366
-95% -$4.56K ﹤0.01% 5652
2026
Q1 		$4.25K Buy
386
+1
+0.3% +$10 ﹤0.01% 4572
2025
Q4 		$3.61K Hold
385
– – ﹤0.01% 4464
2025
Q3 		$2.9K Buy
385
+366
+1,926% +$1.83K ﹤0.01% 3991
2025
Q2 		$64 Hold
19
– – ﹤0.01% 4354
2025
Q1 		$68 Hold
19
– – ﹤0.01% 4103
2024
Q4 		$117 Hold
19
– – ﹤0.01% 3760
2024
Q3 		$102 Buy
+19
New +$89 ﹤0.01% 3774

Other funds holding DSGN

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's DSGN Position: Q3 2026 in Review

Farther Finance Advisors increased its Design Therapeutics (DSGN) stake by 90% in Q3 2026, buying an estimated $249 and bringing the position to 38 shares worth $478. The position accounts for ﹤0.01% of the portfolio, ranked #5754.

Farther Finance Advisors first reported a position in DSGN in Q3 2024 and has held it in 9 quarters since. The position peaked at $4.25K in Q1 2026. 4 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.

  • Farther Finance Advisors held 38 shares of Design Therapeutics worth $478 as of Q3 2026.
  • Farther Finance Advisors bought 18 Design Therapeutics shares in Q3 2026, an estimated $249.
  • Design Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5754 holding.
  • Farther Finance Advisors first reported a position in Design Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • Farther Finance Advisors's Design Therapeutics position peaked at $4.25K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.